Status:
UNKNOWN
The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis
Lead Sponsor:
Beijing Obstetrics and Gynecology Hospital
Conditions:
Intrauterine Adhesion
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
Asherman's syndrome is characterized by the presence of intrauterine adhesions (IUA) as well as symptoms such as amenorrhea, hypomenorrhea, pelvic pain, and infertility. The gold standard for the trea...
Detailed Description
Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double (participant and outcomes Assessor) Primary Purpose: Prevention
Eligibility Criteria
Inclusion
- age 20-40 years；
- previously diagnostic hysteroscopy confirmed adhesion score \>5， according to the American Fertility Society （AFS）classification of IUA；
- complains of menstruation disorder and reproductive dysfunction；
- informed consent.
Exclusion
- premature menopause,
- presence of other intrauterine lesions (e.g. polyps, myoma, septa), and
- presence of severe intercurrent illness (e.g. systemic disease, coagulative disorders, severe kidney and liver diseases),
- adhesions limited to the lower uterine cavity or the cervical canal.
Key Trial Info
Start Date :
November 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 22 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03351205
Start Date
November 21 2017
End Date
November 22 2018
Last Update
November 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Obstetrics and Gynecology Hospital，Capital Medical University
Beijing, China